| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC1265 | Cbz-FTY720 | FTY720 derivative |
|
| DCC1266 | Cc0651 | Novel inhibitor of the E2 ubiquitin-conjugating enzyme Cdc34A |
|
| DCC1267 | Cc-3060 | Novel Cereblon modulator, promoting ZBTB16 degradation by primarily engaging distinct structural degrons on CRBN-ZnF1 zinc finger domains |
|
| DCC1268 | Cc34301 | PqsE inhibitor, binding to the active center inhibiting PqsE's thioesterase activity in cell-based and in vitro assays |
|
| DCC1269 | Cc41801 | PqsE inhibitor, binding to the active center inhibiting PqsE's thioesterase activity in cell-based and in vitro assays |
|
| DCC1270 | Cc-509 | Novel potent orally bioavailable Syk kinase inhibitor |
|
| DCC1271 | Cc-647 | Novel Cereblon modulator, promoting ZBTB16 degradation by primarily engaging distinct structural degrons on CRBN-ZnF3 zinc finger domains |
|
| DCC1272 | Ccdc919159 | Novel Indigoid Anti-tuberculosis Agent; Antimicrobial |
|
| DCC1273 | C-ceritinib Tfa Salt | Novel coupleable ceritinib analog with a linker, also binding multiple other kinases, including FAK1, RSK1/2, ERK1/2, CAMKK2 and FER |
|
| DCC1274 | Ccg-120304 | Novel Inhibitor of TonB Function |
|
| DCC1275 | Ccg-175472 | Novel Inhibitor of TonB Function |
|
| DCC1276 | ccg-206559 | Potent photoprobe as Rho/MKL1/SRF transcription inhibitor |
|
| DCC1277 | Ccg-206584 | Novel inhibitor of G Protein-Coupled Receptor Kinase |
|
| DCC1278 | Ccg-265328 | Novel covalent selective GRK inhibitor, interacting with a nonconserved cysteine (Cys474) |
|
| DCC1279 | Ccg-46842 | Novel sialyltransferase inhibitor (IC 50 : 2 µM) |
|
| DCC1280 | Cci7967 | Novel MmpL3 inhibitor |
|
| DCC1281 | (E/Z)-CCR-11 Featured | (E/Z)-CCR-11 (Comp 12) is a selective CD38 inhibitor, with an IC50 of 20.8 μM against CD38 cyclase. (E/Z)-CCR-11 promotes increases in cellular NAD+ levels and interferon γ. |
.gif)
|
| DCC1282 | Ccr4-in-22 | Novel CCR4 antagonist, enhancing DC activation and homing to the regional lymph node and showing potent vaccine adjuvant activity through the inhibition of regulatory T-cell recruitment |
|
| DCC1283 | Cct245718 | Novel dual FLT3/Aurora A inhibitor, overcoming D835Y-mediated resistance to FLT3 inhibitors in acute myeloid leukaemia cells |
|
| DCC1284 | Cct245731 | Inactive analogue of pictilisib to be used as the negative control |
|
| DCC1285 | Cct245737(s) | Highly Selective Oral Checkpoint Kinase 1 (CHK1) Inhibitor |
|
| DCC1286 | Cct365386 | Novel inhibitor of BCL6 |
|
| DCC1287 | Ccta-1523 | Novel inhibitor of the efflux function of ABCG2, selectively reversing ABCG2-mediated MDR in cancer cells in vitro and in vivo |
|
| DCC1288 | Ccw 28-3 | Novel potent covalent BRD4 degrader, degrading BRD4 in a proteasome- and RNF4-dependent manner without inhibiting RNF4 autoubiquitination activity |
|
| DCC1289 | Cd08108 | Novel MC1R agonist |
|
| DCC1290 | Cd10847 | Novel Caspase-1 inhibitor |
|
| DCC1291 | cd11359 | Novel telomerase inhibitor |
|
| DCC1292 | Cd2019 | Retinoic acid receptor beta (RARbeta) agonist, overcoming inhibition of axonal outgrowth via phosphoinositide 3-kinase signalling in the injured adult spinal cord. |
|
| DCC1293 | Cd22 Glycan Ligand | Novel CD22 glycan ligand, targeting CD22-expressing B cells, uptaking and enhancing siRNA gene expression knockdown via formation of CD22 glycan ligand-conjugated siRNA |
|
| DCC1294 | Cd33 Pre-mrna Splicing Modulator 1 | Novel CD33 pre-mRNA splicing modulator, increasing exon 2 skipping in cellular mRNA pools |
|
